The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
ArticleNo Access

Drug-Induced Extrapyramidal Symptoms: Their Incidence and Treatment

Published Online:https://doi.org/10.1176/ajp.123.7.886

A significant reduction in neuroleptic side effects was found after the addition of antiparkinson medication to the regimen. All but three percent (11) of the patients showed some improvement; 38 percent (141) showed total reduction of symptoms.

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.